Sanno Park Tower 12F (Reception) and 14F,
11-1, Nagatacho 2-chome, Chiyoda-ku,
Tokyo 100-6114, Japan

Tokyo Metro Ginza Line: G06 Tameike-sanno Station, Exit 7 (directly accessible through the second basement)

Tokyo Metro Nanboku Line: N06 Tameike-sanno Station, Exit 7 (directly accessible through the second basement)

Tokyo Metro Chiyoda Line: C07 Kokkai-gijido-mae Station, Exit 5 (3 minutes’ walk)

Tokyo Metro Marunouchi Line: M14 Kokkai-gijido-mae Station, Exit 5 (10 minutes’ walk through Chiyoda Line platform)

Healthcare, Pharmaceuticals and Medical Devices Law

Japan’s healthcare system is now facing major changes, and medical institutions are required to deal with these various changes. As COVID-19 boosted the use of online medical consultation, medical institutions are now encouraged to provide such services while they are also required to address legal and technological requirements to protect personal information. Furthermore, the recent amendment to the Medical Care Act requires medical institutions to build up sustainable management in the face of a super-low birthrate and aging society. As cutting-edge technologies such as regenerative medicine and genetic research continue to evolve, medical institutions are required to keep addressing related laws, systems and governance.
Our firm has a wealth of experience advising clients on healthcare-related legal affairs that are routinely faced by medical institutions, advanced medical fields such as genetic research and regenerative medicine, and personal information protection requirements pertaining to medical institutions, as well as fundamental and high-conflict cases such as succession, ownership or control disputes and governance of medical institutions, and we are prepared to provide comprehensive services in these areas.